Position in MDCX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,343
New position
Shares Held
20,950
first reported quarter
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Wealth Partners, LTD. holds $186,063,127 across 15 Drug Manufacturers - General names. MDCX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
41,007 | $49,185,030 | |
| 2 | ABBV |
AbbVie Inc.
|
168,592 | $42,424,490 | |
| 3 | JNJ |
Johnson & Johnson
|
142,858 | $36,281,646 | |
| 4 | MRK |
Merck & Co., Inc.
|
108,575 | $13,951,887 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
202,756 | $11,682,800 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
81,521 | $10,299,363 | |
| 7 | AMGN |
Amgen Inc
|
25,957 | $9,399,548 | |
| 8 | PFE |
Pfizer Inc
|
210,188 | $5,061,327 |
All Filings in MDCX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,343 | 20,950 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||